PROCEPT BioRobotics Corporation (PRCT) Financial Statements (2024 and earlier)

Company Profile

Business Address 150 BAYTECH DRIVE
SAN JOSE, CA 95134
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments225,576257,222287,087149,691180,972221,859
Cash and cash equivalents225,576257,222287,087149,691180,972221,859
Restricted cash and investments3,0383,0383,8153,8153,8153,815
Receivables56,08148,37634,62233,17320,64215,272
Inventory, net of allowances, customer advances and progress billings41,62239,75642,20142,63638,92628,543
Inventory41,62239,75642,20142,63638,92628,543
Other undisclosed current assets2,8692,1759437011,2253,137
Total current assets:329,186350,567368,668230,016245,580272,626
Noncurrent Assets
Operating lease, right-of-use asset19,89220,24120,69921,56322,44623,481
Property, plant and equipment28,48828,74827,03216,35711,9348,656
Intangible assets, net (including goodwill), including:1,1361,2041,2731,3411,4091,477
Intangible assets, net (excluding goodwill)  (1,300)   (1,000)
Other undisclosed intangible assets, net (including goodwill)1,1362,5041,2731,3411,4092,477
Restricted cash and investments3,0383,0383,0383,0383,0383,038
Other noncurrent assets1,1609194151315151
Total noncurrent assets:53,71454,15052,45742,43038,87836,703
TOTAL ASSETS:382,900404,717421,125272,446284,458309,329
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities21,55330,38426,86219,98517,74922,838
Accounts payable10,08413,49913,59710,03610,3419,391
Accrued liabilities11,46916,88513,2659,9497,40813,447
Deferred revenue5,8605,6565,0074,7173,9432,855
Derivative instruments and hedges, liabilities1,9141,886    
Other liabilities7,6226,3187,7858,8897,8147,468
Other undisclosed current liabilities1,7011,6831,7022,3542,9982,129
Total current liabilities:38,65045,92741,35635,94532,50435,290
Noncurrent Liabilities
Long-term debt and lease obligation51,37151,33951,30751,27551,24151,213
Long-term debt, excluding current maturities51,37151,33951,30751,27551,24151,213
Liabilities, other than long-term debt28,83226,69929,10629,32427,58725,754
Deferred revenue   517357  
Other liabilities517517    
Operating lease, liability28,31526,18226,73027,13525,78223,975
Derivative instruments and hedges, liabilities   1,8591,8321,8051,779
Total noncurrent liabilities:80,20378,03880,41380,59978,82876,967
Total liabilities:118,853123,965121,769116,544111,332112,257
Equity
Equity, attributable to parent264,047280,752299,356155,902173,126197,072
Additional paid in capital744,463735,240726,428558,352550,270545,753
Accumulated other comprehensive income (loss)11384(6)(6)15(6)
Accumulated deficit(480,529)(454,572)(427,066)(402,444)(377,159)(348,675)
Total equity:264,047280,752299,356155,902173,126197,072
TOTAL LIABILITIES AND EQUITY:382,900404,717421,125272,446284,458309,329

Income Statement (P&L) ($ in thousands)

6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
Revenues44,53943,58135,10233,10424,40423,777
Cost of revenue(19,505)(22,326)(16,228)(14,675)(11,913)(13,101)
Gross profit:25,03421,25518,87418,42912,49110,676
Operating expenses(52,683)(50,812)(44,483)(44,054)(40,868)(35,716)
Operating loss:(27,649)(29,557)(25,609)(25,625)(28,377)(25,040)
Interest and debt expense(1,045)(1,125)(1,019)(965)(886)(4,124)
Other undisclosed income from continuing operations before equity method investments, income taxes  7,268   2,011
Net loss:(28,694)(23,414)(26,628)(26,590)(29,263)(27,153)
Other undisclosed net income (loss) attributable to parent2,737(4,090)2,0061,305779(1,019)
Net loss available to common stockholders, diluted:(25,957)(27,504)(24,622)(25,285)(28,484)(28,172)

Comprehensive Income ($ in thousands)

6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
Net loss:(28,694)(23,414)(26,628)(26,590)(29,263)(27,153)
Comprehensive loss:(28,694)(23,414)(26,628)(26,590)(29,263)(27,153)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent2,766(4,000)2,0061,284800(1,242)
Comprehensive loss, net of tax, attributable to parent:(25,928)(27,414)(24,622)(25,306)(28,463)(28,395)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: